[1]
|
Bhamidi, S. (2009) Mycobacterial Cell Wall Arabinogalactan. In: Ullrich, M., Ed., Bacterial Polysaccharides: Current Innovations and Future Trends, Horizon Scientific Press.
|
[2]
|
Falkinham 3rd, J.O. (2015) Environmental Sources of Nontuberculous Mycobacteria. Clinics in Chest Medicine, 36, 35-41. https://doi.org/10.1016/j.ccm.2014.10.003
|
[3]
|
Damaraju, D., Jamieson, F., Chedore, P. and Marras, T.K. (2013) Isolation of Non-Tuberculous Mycobacteria among Patients with Pulmonary Tuberculosis in Ontario, Canada. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 17, 676-681.
https://doi.org/10.5588/ijtld.12.0684
|
[4]
|
Guthertz, L.S., Damsker, B., Bottone, E.J., Ford, E.G., Midura, T.F. and Janda, J.M. (1989) Mycobacterium avium and Mycobacterium intracellulare Infections in Patients with and without Aids. The Journal of Infectious Diseases, 160, 1037-1041.
https://doi.org/10.1093/infdis/160.6.1037
|
[5]
|
Elmer, G.W., Surawicz, C.M. and McFarland, L.V. (1996) Biotherapeutic Agents. A Neglected Modality for the Treatment and Prevention of Selected Intestinal and Vaginal Infections. JAMA, 275, 870-876. https://doi.org/10.1001/jama.1996.03530350052034
|
[6]
|
Sullivan, A. and Nord, C.E. (2002) The Place of Probiotics in Human Intestinal Infections. International Journal of Antimicrobial Agents, 20, 313-319.
https://doi.org/10.1016/S0924-8579(02)00199-1
|
[7]
|
Pothoulakis, C., Kelly, C.P., Joshi, M.A., Gao, N., O’Keane, C.J., Castagliuolo, I. and Lamont, J.T. (1993) Saccharomyces boulardii Inhibits Clostridium difficile Toxin A Binding and Enterotoxicity in Rat Ileum. Gastroenterology, 104, 1108-1115.
https://doi.org/10.1016/0016-5085(93)90280-P
|
[8]
|
Castagliuolo, I., Riegler, M.F., Valenick, L., LaMont, J.T. and Pothoulakis, C. (1999) Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and b in Human Colonic Mucosa. Infection and Immunity, 67, 302-307.
|
[9]
|
Czerucka, D. and Rampal, P. (2002) Experimental Effects of Saccharomyces boulardii on Diarrheal Pathogens. Microbes and Infection, 4, 733-739.
https://doi.org/10.1016/S1286-4579(02)01592-7
|
[10]
|
Bai, X., Ovrutsky, A.R., Kartalija, M., Chmura, K., Kamali, A., Honda, J.R., Oberley-Deegan, R.E., Dinarello, C.A., Crapo, J.D., Chang, L.Y. and Chan, E.D. (2011) Il-32 Expression in the Airway Epithelial Cells of Patients with Mycobacterium avium Complex Lung Disease. International Immunology, 23, 679-691. https://doi.org/10.1093/intimm/dxr075
|
[11]
|
Bai, X., Feldman, N.E., Chmura, K., Ovrutsky, A.R., Su, W.L., Griffin, L., Pyeon, D., McGibney, M.T., Strand, M.J., Numata, M., Murakami, S., Gaido, L., Honda, J.R., Kinney, W.H., Oberley-Deegan, R.E., Voelker, D.R., Ordway, D.J. and Chan, E.D. (2013) Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages. PloS ONE, 8, e61925. https://doi.org/10.1371/journal.pone.0061925
|
[12]
|
Bai, X., Kim, S.H., Azam, T., McGibney, M.T., Huang, H., Dinarello, C.A. and Chan, E.D. (2010) Il-32 Is a Host Protective Cytokine against Mycobacterium tuberculosis in Differentiated Thp-1 Human Macrophages. Journal of Immunology, 184, 3830-3840.
https://doi.org/10.4049/jimmunol.0901913
|
[13]
|
Roebuck, K.A. (2004) Regulation of Interleukin-8 Gene Expression. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research, 19, 429-438. https://doi.org/10.1089/107999099313866
|
[14]
|
Tse, H.M., Josephy, S.I., Chan, E.D., Fouts, D. and Cooper, A.M. (2002) Activation of the Mitogen-Activated Protein Kinase Signaling Pathway Is Instrumental in Determining the Ability of Mycobacterium avium to Grow in Murine Macrophages. Journal of Immunology, 168, 825-833. https://doi.org/10.4049/jimmunol.168.2.825
|
[15]
|
Wang, T., Lafuse, W.P. and Zwilling, B.S. (2001) Nfkappa B and Sp1 Elements Are Necessary for Maximal Transcription of Toll-Like Receptor 2 Induced by Mycobacterium avium. Journal of Immunology, 167, 6924-6932. https://doi.org/10.4049/jimmunol.167.12.6924
|
[16]
|
Ben-Baruch, A., Bengali, K.M., Biragyn, A., Johnston, J.J., Wang, J.M., Kim, J., Chuntharapai, A., Michiel, D.F., Oppenheim, J.J. and Kelvin, D.J. (1995) Interleukin-8 Receptor Beta. The Role of the Carboxyl Terminus in Signal Transduction. The Journal of Biological Chemistry, 270, 9121-9128.
|
[17]
|
Kendall, B.A. and Winthrop, K.L. (2013) Update on the Epidemiology of Pulmonary Nontuberculous Mycobacterial Infections. Seminars in Respiratory and Critical Care Medicine, 34, 87-94. https://doi.org/10.1055/s-0033-1333567
|
[18]
|
Hoefsloot, W., van Ingen, J., Andrejak, C., Angeby, K., Bauriaud, R., Bemer, P., Beylis, N., Boeree, M.J., Cacho Chihota, V., Chimara, E., Churchyard, G., Cias, R., Daza, R., Daley, C.L., Dekhuijzen, P.N., Domingo, D., Drobniewski, F., Esteban, J., Fauville-Dufaux, M., Folkvardsen, D.B., Gibbons, N., Gomez-Mampaso, E., Gonzalez, R., Hoffmann, H., Hsueh, P.R., Indra, A., Jagielski, T., Jamieson, F., Jankovic, M., Jong, E., Keane, J., Koh, W.J., Lange, B., Leao, S., Macedo, R., Mannsaker, T., Marras, T.K., Maugein, J., Milburn, H.J., Mlinko, T., Morcillo, N., Morimoto, K., Papaventsis, D., Palenque, E., Paez-Pena, M., Piersimoni, C., Polanova, M., Rastogi, N., Richter, E., Ruiz-Serrano, M.J., Silva, A., da Silva, M.P., Simsek, H., van Soolingen, D., Szabo, N., Thomson, R., Tortola Fernandez, T., Tortoli, E., Totten, S.E., Tyrrell, G., Vasankari, T., Villar, M., Walkiewicz, R., Winthrop, K.L. and Wagner, D. (2013) The Geographic Diversity of Nontuberculous Mycobacteria Isolated from Pulmonary Samples: An Ntm-Net Collaborative Study. The European Respiratory Journal, 42, 1604-1613. https://doi.org/10.1183/09031936.00149212
|
[19]
|
Ringshausen, F.C., Apel, R.M., Bange, F.C., de Roux, A., Pletz, M.W., Rademacher, J., Suhling, H., Wagner, D. and Welte, T. (2013) Burden and Trends of Hospitalisations Associated with Pulmonary Non-Tuberculous Mycobacterial Infections in Germany, 2005-2011. BMC Infectious Diseases, 13, 231. https://doi.org/10.1186/1471-2334-13-231
|
[20]
|
Russell, C.D., Claxton, P., Doig, C., Seagar, A.L., Rayner, A. and Laurenson, I.F. (2014) Non-Tuberculous Mycobacteria: A Retrospective Review of Scottish Isolates from 2000 to2010. Thorax, 69, 593-595. https://doi.org/10.1136/thoraxjnl-2013-204260
|
[21]
|
Griffith, D.E., Aksamit, T., Brown-Elliott, B.A., Catanzaro, A., Daley, C., Gordin, F., Holland, S.M., Horsburgh, R., Huitt, G., Iademarco, M.F., Iseman, M., Olivier, K., Ruoss, S., von Reyn, C.F., Wallace Jr., R.J. and Winthrop, K. (2007) An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine, 175, 367-416.
https://doi.org/10.1164/rccm.200604-571ST
|
[22]
|
Daley, C.L. and Griffith, D.E. (2010) Pulmonary Non-Tuberculous Mycobacterial Infections. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 14, 665-671.
|
[23]
|
Gareau, M.G., Sherman, P.M. and Walker, W.A. (2010) Probiotics and the Gut Microbiota in Intestinal Health and Disease. Nature Reviews Gastroenterology & Hepatology, 7, 503-514. https://doi.org/10.1038/nrgastro.2010.117
|
[24]
|
Castagliuolo, I., LaMont, J.T., Nikulasson, S.T. and Pothoulakis, C. (1996) Saccharomyces boulardii Protease Inhibits Clostridium difficile Toxin A Effects in the Rat Ileum. Infection and Immunity, 64, 5225-5232.
|
[25]
|
Kelesidis, T. and Pothoulakis, C. (2012) Efficacy and Safety of the Probiotic Saccharomyces boulardii for the Prevention and Therapy of Gastrointestinal Disorders. Therapeutic Advances in Gastroenterology, 5, 111-125. https://doi.org/10.1038/nrgastro.2010.117
|
[26]
|
Sougioultzis, S., Simeonidis, S., Bhaskar, K.R., Chen, X., Anton, P.M., Keates, S., Pothoulakis, C. and Kelly, C.P. (2006) Saccharomyces boulardii Produces a Soluble Anti-Inflammatory Factor that Inhibits Nf-Kappab-Mediated Il-8 Gene Expression. Biochemical and Biophysical Research Communications, 343, 69-76. https://doi.org/10.1016/j.bbrc.2006.02.080
|
[27]
|
Dahan, S., Dalmasso, G., Imbert, V., Peyron, J.F., Rampal, P. and Czerucka, D. (2003) Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells. Infection and Immunity, 71, 766-773.
https://doi.org/10.1128/IAI.71.2.766-773.2003
|
[28]
|
Yamamoto, Y. and Gaynor, R.B. (2001) Therapeutic Potential of Inhibition of the Nf-Kappa B Pathway in the Treatment of Inflammation and Cancer. The Journal of Clinical Investigation, 107, 135-142. https://doi.org/10.1172/JCI11914
|